Placenta derived stem cells for acute kidney injury treatment in a xenogeneic preclinical model

Autor: Romaldas Mačiulaitis, Arvydas Laurinavicius, L. Mickevicius, Justinas Mačiulaitis, A. Gryguc, Neringa Sutkeviciene, Inga Arune Bumblyte
Rok vydání: 2020
Předmět:
Zdroj: Cytotherapy. 22:S203
ISSN: 1465-3249
Popis: Background & Aim Acute kidney injury (AKI) is a life-threatening postoperative complication, affecting 10-30% of treated patients and characterized by the damage to the proximal tubular cells, thereby markedly impairing renal function.1,2,3 15% of patients develop chronic kidney disease (CKD) and fibrosis, eventually managed by hemodialysis and kidney transplantation.4 Mesenchymal stem cells have been shown to possess anti-inflammatory and immunomodulatory properties and be able to aid in tissue repair.5 A link between AKI and CKD has been established and the optimal treatment approach to reduce the high unmet medical need and an economical burden is still being researched.6 Placenta-derived mesenchymal stem cells (PSCs) may be a viable approach to treat AKI and prevent subsequent CKD development. Methods, Results & Conclusion M.: PSCs have been isolated using GMP grade materials, cultivated for three weeks and characterized by yield, viability, flow cytometry and potency in vitro. Wistar rats (8-12 wk) underwent preclinical ischemia-reperfusion injury (IRI). Two experimental groups received treatment. Experimental group (Index) received 3 × 105 of PSCs in the corticomedullar region of each kidney. Control group (Control) received PBS vehicle solution. Survival analysis was carried out till day 7. Urine and blood serum samples were collected on day 0, 3 and 7 and analysed for urine volume/24hrs., protein, creatinine, urea, Na+ and K+. Histological kidney analysis on days 3 and 7 for evaluation of tubular necrosis. R. PSCs had a consistent yield, viability, MSCs markers expression and suppressed proliferation of T cells. Survival rate improved – 100% (Index) vs. 75% (Control). Serum urea and K+ was reduced in index group on day 7 (p Serum creatinine was 1.9 and 1.6 times lower in index group on days 3 and 7, respectively. Na+ was similarly lower after 7 days after PSCs injection. Extensive acute tubular necrosis (ATN) with broad coagulative tubular epithelial necrosis was evident after 3 days in the Control group. Variable extent of ATN without significant coagulative necrosis was observed after 3 and 7 days of Index group. C. Placental derived stem cells have the potential to prevent initial kidney fibrosis cascade through ameliorating initial kidney damage and improving kidney function. A superior 100% survival rate of treated animal group exhibits the potential of characterised PSCs to be used in a larger scale preclinical tumorigenicity and toxicity studies and subsequent clinical first-in-human studies.
Databáze: OpenAIRE
Externí odkaz: